Emergency Department and Laboratory Research (LR12SP18), Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.
Research Laboratory LR12SP18, University of Monastir, 5019, Monastir, Tunisia.
BMC Cardiovasc Disord. 2021 Nov 19;21(1):555. doi: 10.1186/s12872-021-02381-z.
Chest pain remains one of the most challenging serious complaints in the emergency department (ED). A prompt and accurate risk stratification tool for chest pain patients is paramount to help physcian effectively progrnosticate outcomes. HEART score is considered one of the best scores for chest pain risk stratification. However, most validation studies of HEART score were not performed in populations different from those included in the original one.
To validate HEART score as a prognostication tool, among Tunisian ED patients with undifferentiated chest pain.
Our prospective, multicenter study enrolled adult patients presenting with chest pain at chest pain units. Patients over 30 years of age with a primary complaint of chest pain were enrolled. HEART score was calculated for every patient. The primary outcome was major cardiovascular events (MACE) occurrence, including all-cause mortality, non-fatal myocardial infarction (MI), and coronary revascularisation over 30 days following the ED visit. The discriminative power of HEART score was evaluated by the area under the ROC curve. A calibration analysis of the HEART score in this population was performed using Hosmer-Lemeshow goodness of test.
We enrolled 3880 patients (age 56.3; 59.5% males). The application of HEART score showed that most patients were in intermediate risk category (55.3%). Within 30 days of ED visit, MACE were reported in 628 (16.2%) patients, with an incidence of 1.2% in the low risk group, 10.8% in the intermediate risk group and 62.4% in the high risk group. The area under receiver operating characteristic curve was 0.87 (95% CI 0.85-0.88). HEART score was not well calibrated (χ statistic = 12.34; p = 0.03).
HEART score showed a good discrimination performance in predicting MACE occurrence at 30 days for Tunisian patients with undifferentiated acute chest pain. Heart score was not well calibrated in our population.
胸痛仍然是急诊科(ED)最具挑战性的严重主诉之一。对于医生来说,拥有一种快速、准确的胸痛患者风险分层工具至关重要,这有助于医生有效地预测预后。HEART 评分被认为是一种用于胸痛风险分层的最佳评分之一。然而,HEART 评分的大多数验证研究并非在与原始研究人群不同的人群中进行。
验证 HEART 评分作为一种预测工具,用于预测突尼斯 ED 中患有未明确胸痛的患者的预后。
我们进行了一项前瞻性、多中心研究,纳入了胸痛单元就诊的胸痛成年患者。纳入的患者为年龄在 30 岁以上、主诉为胸痛的患者。为每位患者计算 HEART 评分。主要结局为主要心血管事件(MACE)的发生,包括全因死亡率、非致死性心肌梗死(MI)和 ED 就诊后 30 天内的冠状动脉血运重建。通过 ROC 曲线下面积评估 HEART 评分的判别能力。使用 Hosmer-Lemeshow 检验对该人群中的 HEART 评分进行校准分析。
我们共纳入 3880 例患者(年龄 56.3 岁;59.5%为男性)。应用 HEART 评分显示,大多数患者处于中危风险类别(55.3%)。在 ED 就诊后 30 天内,308 例(6.2%)患者发生 MACE,低危组的发生率为 1.2%,中危组为 10.8%,高危组为 62.4%。ROC 曲线下面积为 0.87(95%CI 0.85-0.88)。HEART 评分校准效果不佳(卡方检验=12.34;p=0.03)。
HEART 评分在预测突尼斯患有未明确急性胸痛的患者 30 天内发生 MACE 方面具有良好的判别性能。在我们的人群中,心脏评分的校准效果不佳。